Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Daniel F Quevedo
Introduction
Daniel F Quevedo is an innovative inventor based in Lexington, VA (US). He has made significant contributions to the field of cancer treatment through his research and development of therapeutic protein-based nanoparticles. His work focuses on creating effective solutions for treating intracranial tumors, showcasing his commitment to advancing medical technology.
Latest Patents
Daniel F Quevedo holds a patent for "Therapeutic protein-based nanoparticles for treating cancer." This patent describes a method for forming protein-based nanoparticles via electrohydrodynamic jetting methods. The nanoparticles are characterized by their water-soluble protein composition, which has an average molecular weight ranging from ≥about 8 kDa to ≤about 700 kDa. In certain variations, these proteins are cross-linked to form a mesh structure with an average linear mesh size of ≥about 1 nm to ≤about 4 nm. The nanoparticles may also incorporate therapeutic nucleic acids within their mesh structure, enhancing their efficacy in cancer treatment.
Career Highlights
Daniel F Quevedo is affiliated with the University of Michigan, where he continues to explore innovative approaches to cancer therapy. His research has the potential to transform treatment methodologies and improve patient outcomes. With a focus on practical applications of his inventions, Quevedo is dedicated to making a difference in the medical field.
Collaborations
Daniel has collaborated with notable colleagues such as Joerg Lahann and Nahal Habibi. Their combined expertise contributes to the advancement of research in therapeutic nanoparticles and their applications in medicine.
Conclusion
Daniel F Quevedo's work exemplifies the intersection of innovation and healthcare. His patented technology for therapeutic protein-based nanoparticles represents a promising advancement in cancer treatment. Through his research and collaborations, he is paving the way for new therapeutic strategies that could significantly impact patient care.